Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein phosphatase inhibitor 1 (I-1) is a regulatory protein and a potent inhibitor of protein phosphatase 1 (PP1), a serine/threonine-specific phosphatase involved in various cellular processes. I-1 is activated by phosphorylation, primarily at Thr35 by PKA, which enables it to bind to PP1 and block its activity. It plays a critical role in regulating cardiac physiology and is implicated in heart failure pathogenesis.
Inhibition of protein phosphatase 1 (PP1) activity by binding to the active site when phosphorylated, preventing substrate access.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein Phosphatase Inhibitor 1 (I-1).